High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma
- PMID: 38396039
- PMCID: PMC12105658
- DOI: 10.1245/s10434-024-15074-6
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma
Abstract
Background: Although social vulnerability has been associated with worse postoperative and oncologic outcomes in other cancer types, these effects have not been characterized in patients with soft tissue sarcoma. This study evaluated the association of social vulnerability and oncologic outcomes.
Methods: The authors conducted a single-institution cohort study of adult patients with primary and locally recurrent extremity or truncal soft tissue sarcoma undergoing resection between January 2016 and December 2021. The social vulnerability index (SVI) was measured on a low (SVI 1-39%, least vulnerable) to high (60-100%, most vulnerable) SVI scale. The association of SVI with overall survival (OS) and recurrence-free survival (RFS) was evaluated by Kaplan-Meier analysis and Cox proportional hazard regression.
Results: The study identified 577 patients. The median SVI was 44 (interquartile range [IQR], 19-67), with 195 patients categorized as high SVI and 265 patients as low SVI. The median age, tumor size, histologic subtype, grade, comorbidities, stage, follow-up time, and perioperative chemotherapy and radiation utilization were similar between the high and low SVI cohorts. The patients with high SVI had worse OS (p = 0.07) and RFS (p = 0.016) than the patients with low SVI. High SVI was independently associated with shorter RFS in the multivariate analysis (hazard ratio, 1.64; 95% confidence interval, 1.06-2.54) but not with OS (HR, 1.47; 95% CI 0.84-2.56).
Conclusion: High community-level social vulnerability appears to be independently associated with worse RFS for patients undergoing resection of extremity and truncal soft tissue sarcoma. The effect of patient and community-level social risk factors should be considered in the treatment of patients with extremity sarcoma.
Keywords: Social determinants of health; Social vulnerability; Soft-tissue sarcoma.
© 2024. Society of Surgical Oncology.
Conflict of interest statement
Conflicts of interest:
The authors have no relevant conflicts of interest to disclose
Figures




Similar articles
-
Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.Ann Surg Oncol. 2019 Oct;26(11):3542-3549. doi: 10.1245/s10434-019-07639-7. Epub 2019 Jul 24. Ann Surg Oncol. 2019. PMID: 31342400
-
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.J Surg Res. 2020 Jan;245:577-586. doi: 10.1016/j.jss.2019.08.002. Epub 2019 Sep 5. J Surg Res. 2020. PMID: 31494391
-
Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.J Surg Oncol. 2021 Feb;123(2):479-488. doi: 10.1002/jso.26275. Epub 2020 Nov 4. J Surg Oncol. 2021. PMID: 33150594 Free PMC article.
-
The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.Ann Surg Oncol. 2019 Dec;26(13):4723-4729. doi: 10.1245/s10434-019-07805-x. Epub 2019 Sep 9. Ann Surg Oncol. 2019. PMID: 31502023 Free PMC article.
-
The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.Ann Surg Oncol. 2017 Nov;24(12):3574-3586. doi: 10.1245/s10434-017-6034-9. Epub 2017 Sep 11. Ann Surg Oncol. 2017. PMID: 28895084
Cited by
-
The Relationship Between Area-Level Marginalization and Overall Survival of Patients with Soft Tissue Sarcoma in Ontario: A Retrospective Cohort Study.Ann Surg Oncol. 2025 May;32(5):3716-3723. doi: 10.1245/s10434-025-16986-7. Epub 2025 Feb 18. Ann Surg Oncol. 2025. PMID: 39966273
References
-
- (WHO), W.H.O., Social Determinants of Health. https://health.gov/healthypeople/priority-areas/social-determinants-health.
-
- Control, C.f.D., CDC/ATSDR Social Vulnerability Index. 2018, https://www.atsdr.cdc.gov/placeandhealth/svi/index.html.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical